PTC Therapeutics (PTCT) Insider Trading & Ownership

$76.82 0.00 (0.00%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$76.74 -0.07 (-0.10%)

As of 07/24/2026 07:34 PM Eastern

Compare

Current Insider Ownership Percentage: 5.50%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 13
Amount Of Insider Selling (Last 12 Months): $64.59M

Get PTCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTCT Insider Buying and Selling by Quarter

PTC Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export

Transaction Date	Insider	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/9/2026	Mary L Smith Director	Sell	15,834	$90.00	$1,425,060.00
7/9/2026	Neil Gregory Almstead Insider	Sell	2,464	$90.25	$222,376.00
7/7/2026	Neil Gregory Almstead Insider	Sell	24,613	$88.89	$2,187,849.57
7/6/2026	Mark Elliott Boulding VP	Sell	5,079	$85.08	$432,121.32
7/6/2026	Neil Gregory Almstead Insider	Sell	22,161	$86.00	$1,905,846.00
6/26/2026	Neil Gregory Almstead Insider	Sell	8,130	$85.26	$693,163.80
6/25/2026	Neil Gregory Almstead Insider	Sell	20,960	$85.97	$1,801,931.20
6/24/2026	Neil Gregory Almstead Insider	Sell	5,323	$85.03	$452,614.69
6/22/2026	Neil Gregory Almstead Insider	Sell	23,749	$80.90	$1,921,294.10
6/17/2026	Christine Marie Utter CAO	Sell	19,686	$75.56	$1,487,474.16
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
6/17/2026	Mark Elliott Boulding VP	Sell	10,462	$78.65	$822,836.30
6/10/2026	Eric Pauwels Insider	Sell	21,277	$75.00	$1,595,775.00
5/15/2026	Mark Elliott Boulding VP	Sell	2,812	$72.18	$202,970.16
5/14/2026	Matthew B Klein CEO	Sell	12,572	$72.95	$917,127.40
5/8/2026	Mark Elliott Boulding VP	Sell	3,540	$78.97	$279,553.80
4/21/2026	Matthew B Klein CEO	Sell	2,850	$70.91	$202,093.50
4/6/2026	Mark Elliott Boulding VP	Sell	2,265	$69.45	$157,304.25
4/2/2026	Lee Scott Golden EVP	Sell	829	$67.99	$56,363.71
4/1/2026	Neil Gregory Almstead Insider	Sell	52,003	$69.04	$3,590,287.12
3/12/2026	Matthew B Klein CEO	Sell	2,662	$64.08	$170,580.96
3/10/2026	Stephanie Okey Director	Sell	15,167	$70.00	$1,061,690.00
3/5/2026	Lee Scott Golden EVP	Sell	10,000	$63.38	$633,800.00
3/5/2026	Neil Gregory Almstead Insider	Sell	3,989	$63.38	$252,822.82
3/5/2026	Stephanie Okey Director	Sell	6,333	$63.38	$401,385.54
2/19/2026	Mark Elliott Boulding VP	Sell	3,019	$69.48	$209,760.12
2/18/2026	Christine Marie Utter CAO	Sell	2,494	$69.36	$172,983.84
2/18/2026	Eric Pauwels Insider	Sell	3,019	$69.36	$209,397.84
2/18/2026	Lee Scott Golden EVP	Sell	2,484	$69.36	$172,290.24
2/18/2026	Mark Elliott Boulding VP	Sell	3,081	$69.36	$213,698.16
2/18/2026	Matthew B Klein CEO	Sell	7,371	$69.36	$511,252.56
2/18/2026	Neil Gregory Almstead Insider	Sell	3,056	$69.36	$211,964.16
2/18/2026	Neil Gregory Almstead Insider	Sell	65	$69.36	$4,508.40
2/18/2026	Pierre Gravier CFO	Sell	2,992	$69.36	$207,525.12
2/17/2026	Mark Elliott Boulding VP	Sell	2,813	$69.29	$194,912.77
1/12/2026	Eric Pauwels Insider	Sell	1,024	$78.70	$80,588.80
1/9/2026	Eric Pauwels Insider	Sell	1,722	$77.41	$133,300.02
1/9/2026	Mark Elliott Boulding VP	Sell	2,314	$77.93	$180,330.02
1/8/2026	Christine Marie Utter CAO	Sell	1,034	$76.45	$79,049.30
1/8/2026	Eric Pauwels Insider	Sell	4,602	$76.50	$352,053.00
1/8/2026	Lee Scott Golden EVP	Sell	866	$76.45	$66,205.70
SPCX Warning - and Worst News for Stocks in 50 Years (Ad) Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits. Learn how to prepare your portfolio for what's coming next
1/8/2026	Mark Elliott Boulding VP	Sell	4,033	$76.56	$308,766.48
1/8/2026	Matthew B Klein CEO	Sell	2,514	$76.45	$192,195.30
1/8/2026	Neil Gregory Almstead Insider	Sell	881	$76.45	$67,352.45
1/8/2026	Neil Gregory Almstead Insider	Sell	59	$76.45	$4,510.55
1/7/2026	Christine Marie Utter CAO	Sell	1,235	$77.45	$95,650.75
1/7/2026	Eric Pauwels Insider	Sell	1,352	$77.48	$104,752.96
1/7/2026	Lee Scott Golden EVP	Sell	642	$77.48	$49,742.16
1/7/2026	Mark Elliott Boulding VP	Sell	4,879	$77.44	$377,829.76
1/7/2026	Matthew B Klein CEO	Sell	3,016	$77.48	$233,679.68
1/7/2026	Neil Gregory Almstead Insider	Sell	1,026	$77.48	$79,494.48
1/7/2026	Neil Gregory Almstead Insider	Sell	52	$77.48	$4,028.96
1/6/2026	Christine Marie Utter CAO	Sell	1,381	$76.95	$106,267.95
1/6/2026	Eric Pauwels Insider	Sell	1,789	$76.95	$137,663.55
1/6/2026	Lee Scott Golden EVP	Sell	1,340	$76.95	$103,113.00
1/6/2026	Mark Elliott Boulding VP	Sell	1,739	$76.95	$133,816.05
1/6/2026	Matthew B Klein CEO	Sell	5,149	$76.95	$396,215.55
1/6/2026	Neil Gregory Almstead Insider	Sell	1,279	$76.95	$98,419.05
1/6/2026	Neil Gregory Almstead Insider	Sell	54	$76.95	$4,155.30
1/6/2026	Pierre Gravier CFO	Sell	2,139	$76.95	$164,596.05
1/5/2026	Emma Reeve Director	Sell	734	$76.00	$55,784.00
1/5/2026	Mark Elliott Boulding VP	Sell	2,266	$75.55	$171,196.30
1/2/2026	Glenn Md Phd Steele Jr Director	Sell	12,000	$76.35	$916,200.00
12/30/2025	Matthew B Klein CEO	Sell	8,089	$76.64	$619,940.96
12/19/2025	Eric Pauwels Insider	Sell	20,508	$77.26	$1,584,448.08
12/18/2025	Eric Pauwels Insider	Sell	3,202	$75.06	$240,342.12
12/17/2025	Eric Pauwels Insider	Sell	40,290	$75.43	$3,039,074.70
12/3/2025	Emma Reeve Director	Sell	733	$78.62	$57,628.46
12/2/2025	Matthew B Klein CEO	Sell	3,428	$79.07	$271,051.96
11/25/2025	Allan Steven Jacobson Director	Sell	14,199	$83.55	$1,186,326.45
11/25/2025	Neil Gregory Almstead Insider	Sell	71,928	$83.44	$6,001,672.32
11/24/2025	Allan Steven Jacobson Director	Sell	11,801	$80.14	$945,732.14
11/24/2025	Neil Gregory Almstead Insider	Sell	35,572	$80.18	$2,852,162.96
11/21/2025	Emma Reeve Director	Sell	10,000	$79.50	$795,000.00
11/17/2025	Mark Elliott Boulding VP	Sell	2,812	$75.99	$213,683.88
11/12/2025	Emma Reeve Director	Sell	7,333	$74.50	$546,308.50
10/30/2025	Emma Reeve Director	Sell	15,666	$69.50	$1,088,787.00
10/7/2025	Mark Elliott Boulding VP	Sell	3,375	$63.43	$214,076.25
10/6/2025	Mark Elliott Boulding VP	Sell	2,266	$65.07	$147,448.62
10/3/2025	Allan Steven Jacobson Director	Sell	12,000	$65.00	$780,000.00
10/3/2025	Emma Reeve Director	Sell	25,562	$65.96	$1,686,069.52
10/3/2025	Mark Elliott Boulding VP	Sell	22,655	$65.82	$1,491,152.10
10/3/2025	Neil Gregory Almstead Insider	Sell	55,000	$66.05	$3,632,750.00
9/12/2025	Mark Elliott Boulding VP	Sell	24,585	$61.34	$1,508,043.90
9/11/2025	Emma Reeve Director	Sell	15,705	$59.50	$934,447.50
9/11/2025	Mark Elliott Boulding VP	Sell	22,664	$61.00	$1,382,504.00
9/9/2025	David P Southwell Director	Sell	12,000	$58.34	$700,080.00
9/8/2025	Eric Pauwels Insider	Sell	39,850	$56.92	$2,268,262.00
8/28/2025	Allan Steven Jacobson Director	Sell	1,667	$50.15	$83,600.05
8/28/2025	Allan Steven Jacobson Director	Sell	1,667	$50.15	$83,600.05
8/5/2025	Matthew B Klein CEO	Sell	10,739	$51.74	$555,635.86
SPCX Warning - and Worst News for Stocks in 50 Years (Ad) Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits. Learn how to prepare your portfolio for what's coming next

(Data available from 1/1/2013 forward)

PTCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at PTC Therapeutics includes Alethia Young, Allan Steven Jacobson, Christine Marie Utter, David P Southwell, Emma Reeve, Eric Pauwels, Glenn Md Phd Steele Jr, Jerome B Zeldis, Lee Scott Golden, Mark Elliott Boulding, Mary L Smith, Matthew B Klein, Michael Schmertzler, Neil Gregory Almstead, Pierre Gravier, and Stephanie Okey. Learn more on insiders at PTCT.

5.50% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings.

The following insiders have sold PTCT shares in the last 24 months: Allan Steven Jacobson ($3,142,628.29), Christine Marie Utter ($2,965,503.84), David P Southwell ($700,080.00), Emma Reeve ($5,164,024.98), Eric Pauwels ($9,887,194.53), Glenn Md Phd Steele Jr ($916,200.00), Jerome B Zeldis ($1,236,000.00), Lee Scott Golden ($1,200,183.86), Mark Elliott Boulding ($14,209,189.34), Mary L Smith ($1,425,060.00), Matthew B Klein ($4,580,320.33), Neil Gregory Almstead ($29,732,462.03), Pierre Gravier ($555,079.33), and Stephanie Okey ($1,733,075.54).

Insiders have sold a total of 1,130,941 PTC Therapeutics shares in the last 24 months for a total of $77,447,002.07 sold.

PTC Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

Related Companies

Insider Tracking Tools

Insider Trading By Country

Latest Articles

This page (NASDAQ:PTCT) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PTC Therapeutics (PTCT) Insider Trading & Ownership

PTCT Insider Buying and Selling by Quarter

PTC Therapeutics Insider and Congressional Trades History

PTCT Insider Trading Activity - Frequently Asked Questions

PTC Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PTC Therapeutics (PTCT) Insider Trading & Ownership

PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling Activity

PTCT Insider Buying and Selling by Quarter

PTC Therapeutics Insider and Congressional Trades History

PTCT Insider Trading Activity - Frequently Asked Questions

Who is on PTC Therapeutics' Insider Roster?

What percentage of PTC Therapeutics stock is owned by insiders?

Which PTC Therapeutics insiders have been selling company stock?

How much insider selling is happening at PTC Therapeutics?

PTC Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools